Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

1526 ARTÍCULOS , VIENDO DEL 1441 AL 1455

Potential for Treatment of Neurodegenerative Diseases with Natural Products or Synthetic Compounds that Stabilize Microtubules

Miller JH, Das V.

Curr Pharm Des. 2020;26(35):4362-4372. doi: 10.2174/1381612826666200621171302.

Progress toward Alzheimer's disease treatment: Leveraging the Achilles' heel of Aβ oligomers?

Fantini J, Chahinian H, Yahi N.

Protein Sci. 2020 Aug;29(8):1748-1759. doi: 10.1002/pro.3906. Epub 2020 Jul 13.

Rapid improvement in Alzheimer's disease symptoms following fecal microbiota transplantation: a case report

Hazan S.

J Int Med Res. 2020 Jun;48(6):300060520925930. doi: 10.1177/0300060520925930.

A Comparison of Serial Position Effects in Patients with Mild Cognitive Impairment due to Parkinson's Disease or to Alzheimer's Disease

Meyer A, Handabaka I, Ehrensperger MM, Gschwandtner U, Hatz F, Monsch AU, Stieglitz RD, Fuhr P.

Dement Geriatr Cogn Disord. 2020;49(2):170-178. doi: 10.1159/000507757. Epub 2020 Jul 7.

Epigenetic Basis of Lead-Induced Neurological Disorders

Wang T, Zhang J, Xu Y.

Int J Environ Res Public Health. 2020 Jul 7;17(13):4878. doi: 10.3390/ijerph17134878.

Endosomal Trafficking in Alzheimer's Disease, Parkinson's Disease, and Neuronal Ceroid Lipofuscinosis

Qureshi YH, Baez P, Reitz C.

Mol Cell Biol. 2020 Sep 14;40(19):e00262-20. doi: 10.1128/MCB.00262-20. Print 2020 Sep 14.

New antipsychotic drugs for the treatment of agitation and psychosis in Alzheimer's disease: focus on brexpiprazole and pimavanserin

Caraci F, Santagati M, Caruso G, Cannavò D, Leggio GM, Salomone S, Drago F.

F1000Res. 2020 Jul 8;9:F1000 Faculty Rev-686. doi: 10.12688/f1000research.22662.1. eCollection 2020.

The Functional Roles and Applications of Immunoglobulins in Neurodegenerative Disease

Sim KY, Im KC, Park SG.

Int J Mol Sci. 2020 Jul 26;21(15):5295. doi: 10.3390/ijms21155295.

Endosomal-lysosomal dysfunction in metabolic diseases and Alzheimer's disease

Almeida MF, Bahr BA, Kinsey ST.

Int Rev Neurobiol. 2020;154:303-324. doi: 10.1016/bs.irn.2020.02.012. Epub 2020 Jul 10.

The NLRP3 inflammasome as a bridge between neuro-inflammation in metabolic and neurodegenerative diseases

Söderbom G, Zeng BY.

Int Rev Neurobiol. 2020;154:345-391. doi: 10.1016/bs.irn.2020.03.023. Epub 2020 Jul 17.

[Mitochondrial genome variants and neurodegenerative diseases]

Ni J, Wang J.

Zhonghua Yi Xue Yi Chuan Xue Za Zhi. 2020 Aug 10;37(8):898-902. doi: 10.3760/cma.j.issn.1003-9406.2020.08.023.

Glucose transporters in brain in health and disease

Koepsell H.

Pflugers Arch. 2020 Sep;472(9):1299-1343. doi: 10.1007/s00424-020-02441-x. Epub 2020 Aug 13.

Tackling challenges in care of Alzheimer's disease and other dementias amid the COVID-19 pandemic, now and in the future

Mok VCT, Pendlebury S, Wong A, Alladi S, Au L, Bath PM, Biessels GJ, Chen C, Cordonnier C, Dichgans M, Dominguez J, Gorelick PB, Kim S, Kwok T, Greenberg SM, Jia J, Kalaria R, Kivipelto M, Naegandran K, Lam LCW, Lam BYK, Lee ATC, Markus HS, O'Brien J, Pai MC, Pantoni L, Sachdev P, Skoog I, Smith EE, Srikanth V, Suh GH, Wardlaw J, Ko H, Black SE, Scheltens P.

Alzheimers Dement. 2020 Nov;16(11):1571-1581. doi: 10.1002/alz.12143. Epub 2020 Aug 12.

Current Aspects of the Endocannabinoid System and Targeted THC and CBD Phytocannabinoids as Potential Therapeutics for Parkinson's and Alzheimer's Diseases: a Review

Cooray R, Gupta V, Suphioglu C.

Mol Neurobiol. 2020 Nov;57(11):4878-4890. doi: 10.1007/s12035-020-02054-6. Epub 2020 Aug 19.

Chronic Traumatic Encephalopathy: A Comparison with Alzheimer's Disease and Frontotemporal Dementia

Lesman-Segev OH, Edwards L, Rabinovici GD.

Semin Neurol. 2020 Aug;40(4):394-410. doi: 10.1055/s-0040-1715134. Epub 2020 Aug 20.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias